Clearside Biomedical's market cap is currently $78.12M. The company's EPS TTM is $-0.45; its P/E ratio is ―; Clearside Biomedical is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 8.23M	$ 1.33M	$ 29.57M	$ 7.89M	$ 2.17M
Gross Profit	$ 7.87M	$ 1.12M	$ 29.40M	$ 7.89M	$ 2.17M
Operating Income	$ -24.84M	$ -30.28M	$ -627.00K	$ -17.93M	$ -30.30M
EBITDA	$ -23.06M	$ -29.46M	$ -449.00K	$ -17.93M	$ -30.09M
Net Income	$ -32.48M	$ -34.07M	$ 376.00K	$ -18.03M	$ -30.56M
Balance Sheet
Cash & Short-Term Investments	$ 28.92M	$ 48.26M	$ 30.44M	$ 17.29M	$ 22.59M
Total Assets	$ 34.02M	$ 51.30M	$ 42.90M	$ 19.32M	$ 26.78M
Total Debt	$ 43.00M	$ 1.28M	$ 675.00K	$ 1.98M	$ 6.41M
Net Debt	$ 14.08M	$ -46.97M	$ -29.76M	$ -15.31M	$ -16.19M
Total Liabilities	$ 49.93M	$ 40.70M	$ 4.93M	$ 10.56M	$ 15.62M
Stockholders' Equity	$ -15.91M	$ 10.61M	$ 37.98M	$ 8.76M	$ 11.16M
Cash Flow
Free Cash Flow	$ -19.91M	$ -13.61M	$ -10.73M	$ -13.18M	$ -27.09M
Operating Cash Flow	$ -18.14M	$ -13.37M	$ -10.73M	$ -13.12M	$ -27.07M
Investing Cash Flow	$ -1.78M	$ -246.00K	$ 0.00	$ -55.00K	$ 32.92M
Financing Cash Flow	$ 414.00K	$ 31.33M	$ 23.78M	$ 7.87M	$ 8.70M

Currency in USD

Clearside Biomedical Earnings and Revenue History

Income Statement >

Clearside Biomedical Debt to Assets

Balance Sheet >

Clearside Biomedical Cash Flow

Cash Flow >

Clearside Biomedical Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing